Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.67 USD -1.84%
Market Cap: 786.8m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Net Margin
Abcellera Biologics Inc

-533.3%
Current
-145%
Average
0.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-533.3%
=
Net Income
-175.8m
/
Revenue
33m

Net Margin Across Competitors

Country CA
Market Cap 773.6m USD
Net Margin
-533%
Country US
Market Cap 1.4T USD
Net Margin
9%
Country US
Market Cap 211.3B USD
Net Margin
14%
Country US
Market Cap 177.6B USD
Net Margin
18%
Country KR
Market Cap 71.2T KRW
Net Margin
24%
Country CH
Market Cap 39.5B CHF
Net Margin
9%
Country US
Market Cap 39.8B USD
Net Margin
9%
Country US
Market Cap 39.3B USD
Net Margin
22%
Country US
Market Cap 27.8B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
-36%
Country US
Market Cap 23.5B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Abcellera Biologics Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-533.3%
=
Net Income
-175.8m
/
Revenue
33m
What is the Net Margin of Abcellera Biologics Inc?

Based on Abcellera Biologics Inc's most recent financial statements, the company has Net Margin of -533.3%.